| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer
1 company
MacHatha Stephen is a Chief Development Officer at Aldeyra Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $435K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 11, 2025 | ALDX Aldeyra Therapeutics, Inc. | Chief Development Officer | Sell | 22,073 | $5.15 | $113,713.47 | -9.1% | -2.3% | - | |
| Aug 12, 2024 | ALDX Aldeyra Therapeutics, Inc. | Chief Development Officer | Sell | 16,041 | $4.74 | $75,974.99 | -6.3% | +15.6% | +12.8% | |
| Mar 12, 2024 | ALDX Aldeyra Therapeutics, Inc. | Chief Development Officer | Sell | 29,768 | $3.31 | $98,605.15 | -5.6% | +28.8% | +132.3% |